tnf inhibitor panel discussion: acr21 annual meeting
Published 3 years ago • 264 plays • Length 17:51Download video MP4
Download video MP3
Similar videos
-
10:42
tnf inhibitors rise to the top: drs. janet pope and david liew
-
20:22
consequences of tnf inhibition
-
21:12
ra panel: safety, multimorbidities, vaccination and the weather
-
5:14
cardiovascular disease for tnfi vs jaki: dr jon giles
-
12:13
rheumnow roundtable on psoriatic arthritis
-
35:16
the expert gout panel with drs. neogi, saag, pillinger, cush and o'dell
-
28:17
eular 2021 ra panel discussion with drs. cush, kay, dao, liew and el ramahi
-
2:54
switching moa after failing the 1st tnf inhibitor
-
22:59
spondyloarthritis roundtable rehash of acr 2021
-
3:58
qd26 - breast cancer & a tnf inhibitor
-
59:50
rheumnow rheumatology roundup: drs. kavanaugh and cush
-
2:09
jak vs tnf inhibitor infections in ra
-
31:51
acr21 day 1 recap: drs. cush, najm, mehta, yusof, castillo, conway
-
4:34
might tofacitinib reduce malignancy risk with patients with ra? dr. jonathan kay
-
32:52
acr21 opening day recap: drs. cush, dao, tate and reyes
-
1:39
2020 ttf egfr session qa panel what is the difference between c797s and c797x
-
20:25
oral surveillance tofacitinib safety panel
-
12:52
sle panel: learning about lupus at acr 2021
-
10:39
iraes: drs. cassie calabrese and david liew